Wednesday, February 10, 2010, 7:01am EST - Canadian Markets open in 2 hours and 29 minutes.
To create a watchlist or portfolio of shares, Sign-in or Register

Alkermes, Inc. (ALKS)

 On Feb 9: 11.43 USD   0.00 (0.00%)  
MORE ON ALKS
Quotes
HereSummary
Charts
News & Info
Company
Analyst Coverage
Ownership
Financials
Alkermes, Inc. (NasdaqNM:ALKS) Delayed quote dataEdit
Last Trade: 11.43 USD
Trade Time: Feb 9
Change: 0.00 (0.00%)
Prev Close: 11.43
Open: N/A
Bid: N/A
Ask: 11.94 x 100
1y Target Est: 12.57
Day's Range: N/A - N/A
52wk Range: 7.41 - 13.16
Volume: 0
Avg Vol (3m): 1,184,200
Market Cap: 1.08B
P/E (ttm): 13.57
EPS (ttm): 0.84
Div & Yield: N/A (N/A%)
Alkermes, Inc. (ALKS)
1d  5d  3m  6m  1y  2y  5y  max 
Free Annual Reports
 Add ALKS to Portfolio   Download Data

HEADLINES
• Alkermes Retains Neutral Rec
Zacks.com (Mon, Feb 8)
• [video] Alkermes CEO Sounds Off
at CNBC (Mon, Feb 8)
• New Star Analyst Rankings for Alkermes, Inc.
StarMine (Sat, Feb 6)
• [$$] Russell 2000 Falls for Fourth Week in a Row
at The Wall Street Journal Online (Fri, Feb 5)
• Biotech Stocks: Drug stocks fall; Alkermes rallies on upgrade
at MarketWatch (Fri, Feb 5)
• Biotech Stocks: Drug stocks slip; Alkermes rallies on upgrade
at MarketWatch (Fri, Feb 5)
• Lower Q3 Loss for Alkermes
Zacks.com (Fri, Feb 5)
• Drug stocks dip; Alkermes jumps on upgrade
at MarketWatch (Fri, Feb 5)
• Premarket roundup: PerkinElmer, NCR
AP (Fri, Feb 5)
• Ahead of the Bell: Alkermes upgraded on 3Q results
AP (Fri, Feb 5)
• Wall Street Breakfast: Must-Know News
at Seeking Alpha (Fri, Feb 5)
• Alkermes upgraded by Jefferies & Co
Briefing.com (Fri, Feb 5)
• Alkermes, Inc. F3Q10 (Qtr End 12/31/09) Earnings Call Transcript
at Seeking Alpha (Thu, Feb 4)
More Headlines for ALKS...
ANALYST
EPS Est (next year) (Mar-10) : -0.41
EPS Est (in 2 years) (Mar-11) : -0.10
Avg Rec (current)*: 2.4
PEG Ratio: N/A
* (Strong Buy) 1.0 - 5.0 (Strong Sell)
Analyst Opinion - Estimates

BUSINESS SUMMARY
Alkermes, Inc., an integrated biotechnology company, offers extended-release injectable, pulmonary, and oral products for the treatment of prevalent, chronic diseases, such as central nervous system disorders, addiction, and diabetes.

Full Company Profile

Add to My Portfolio Add to Portfolio    Email to a Friend Email to a Friend
Get Summary for Another Symbol:
Symbol Lookup
• Latest News • Canadian Indices